NCT00126503 · Interventional trial
Sorafenib Tosylate and Bevacizumab in Treating Patients With Advanced Kidney Cancer
Overall registry status Completed
Phase 1 · Phase 2
Conditions Chromophobe Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Recurrent Renal Cell Carcinoma, Sarcomatoid Renal Cell Carcinoma, Stage IV Renal Cell Cancer
Delaware Valley sites
- University of Pennsylvania/Abramson Cancer Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory